Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000040

CEO bought 75,000 shares at an average $0.02 ($1,211)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-18 Purchase : show line 1 in the form +2,000 $0.01 $27 24,356,097 D
2019-06-18 Purchase : show line 2 in the form +5,000 $0.01 $67 24,361,097 D
2019-06-18 Purchase : show line 3 in the form +10,000 $0.01 $133 24,371,097 D
2019-06-18 Purchase : show line 4 in the form +1,000 $0.01 $13 24,372,097 D
2019-06-21 Purchase : show line 5 in the form +20,000 $0.02 $382 24,392,097 D
2019-06-21 Purchase : show line 6 in the form +5,000 $0.02 $98 24,397,097 D
2019-06-26 Purchase : show line 7 in the form +30,000 $0.02 $462 24,427,097 D
2019-06-26 Purchase : show line 8 in the form +2,000 $0.02 $30 24,429,097 D
Open-market purchases · 75,000 sh · avg $0.02 · $1,211
Loading xslF345X03/primary_doc.xml…